跳至主要内容
临床试验/TCTR20200604001
TCTR20200604001已完成未知

Incidence and survival of hepatocellular carcinoma in type 2 diabetes with cirrhosis who were treated with Metformin

Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 1,061 人开始时间: 2020年6月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,061

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20 Years 至 80 Years(—)
性别
All

入选标准

  • 1) patients had to be 20-80 years old
  • 2) Diagnosed with T2D Using diagnostic criteria From the American Diabetes Association, (ADA) or self-reported medical history or physician note even or taking anti diabetic agents
  • 3) the diagnosis of cirrhosis was diagnosed by histology or clinical features or radiological images
  • 4) T2D was diagnosed before the onset of cirrhosis and HCC
  • 5) T2D has been newly diagnosed with cirrhosis of various causes in the period from 2006-2014.

排除标准

  • 1) patients who underwent liver transplantation
  • 2) patients were follow up at Siriraj hospital less than 5 years
  • 3) diagnosis of cirrhosis along with HCC or diagnosed with HCC after diagnosis of cirrhosis in less than 1 year
  • 4) incomplete clinical information.

研究者

发起方
Faculty of Medicine Siriraj Hospital, Mahidol University

相似试验

Incidence and survival of hepatocellular carcinoma... | 临床试验